Ovid Therapeutics Inc. · NASDAQ:OVID
Janus Henderson Group PLC reported a 9.99% stake in Ovid Therapeutics Inc. (Schedule 13G)
Event Nov 28, 2025 · Filed Dec 8, 2025
Janus Henderson Group PLC reported a 9.99% stake in Ovid Therapeutics Inc., 7,114,114 shares, as a passive investor on Nov 28, 2025. Filed Dec 8, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 7,114,114
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.99% | 7,114,114 |
Source
Related
- Ovid Therapeutics Inc.
- Janus Henderson Group PLC
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026